UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~September~~October 1024, 2025

Lite Strategy, Inc.

(Exact name of Registrant as Specified in Its Charter)


Delaware	001-41827	51-0407811
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

9920 Pacific Heights Blvd., Suite 150
San Diego, California		92121
(Address of Principal Executive Offices)		(Zip Code)

     Registrant’s Telephone Number, Including Area Code: 858 369-7100

    

MEI Pharma, Inc.

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.00000002 par value	LITS	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 35.02 UnregisteredDeparture Salesof Directors or Certain Officers; Election of EquityDirectors; SecuritiesAppointment of Certain Officers; Compensatory Arrangements of Certain Officers.

AsOn ~~previously~~October ~~reported~~24, on2025, ~~July~~Thomas ~~22,~~C. ~~2025~~Reynolds, ~~Lite Strategy~~M.D., ~~Inc~~Ph.D. informed the board of directors (the “~~Company~~Board”) ~~issued~~of ~~pre-funded~~Lite ~~warrants~~Strategy, Inc. (the “~~Pre-Funded Warrants~~Company”) toof ~~purchase~~his updecision to anresign ~~aggregate~~as ofa ~~6,022,869~~director ~~shares~~ of the Company~~’s Common Stock~~, ~~par~~including ~~value~~from ~~$0.00000002~~his ~~per~~positions ~~share~~as ~~(the~~a ~~“Common~~member ~~Stock”), at an offering price~~ of ~~$3.4199~~the ~~per~~Compensation ~~Pre-Funded~~Committee ~~Warrant. The Pre-Funded Warrants were immediately exercisable,~~ and ~~were~~Nominating ~~issued~~& toGovernance ~~one~~Committee of the ~~investors~~Board, ~~under~~effective ~~the~~on ~~securities~~November ~~purchase~~4, ~~agreements~~2025. ~~entered~~Dr. ~~into~~Reynolds' ondecision ~~July~~to ~~17,~~resign ~~2025~~from by the ~~Company~~Board ~~and~~is not the ~~various~~result ~~purchasers~~of ~~thereunder~~any indisagreement awith ~~private~~the ~~placement~~Company’s ~~offering~~operations, ~~(the~~policies ~~“PIPE~~or ~~Offering”)~~practices.

OnThe ~~September~~Company ~~10,~~is ~~2025,~~tremendously ~~the~~grateful ~~above-referenced~~for ~~investor~~Dr. ~~exercised~~Reynolds’s ~~1,595,000~~valuable ~~Pre-Funded~~insights ~~Warrants~~and incontributions aduring ~~cashless~~the ~~exercise~~time tohe ~~purchase~~served ~~1,594,944~~on ~~shares~~the ~~of Common Stock~~Board.

Item The8.01 CompanyOther relied upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder for transactions by an issuer not involving a public offering to issue the Pre-Funded Warrant and shares of Common Stock issuable upon the exercise of the Pre-Funded WarrantEvents.

On ~~The~~October ~~description~~29, of2025, the ~~Pre-Funded~~Company ~~Warrant~~issued isa ~~qualified~~press inrelease ~~its~~announcing ~~entirety~~that by the ~~full~~Board ~~text~~authorized ofa common stock repurchase program (the ~~form~~“Stock ofRepurchase ~~Pre-Funded~~Program”) ~~Warrant~~under which isthe ~~filed~~Company may purchase up to $25 million of its common stock as ~~Exhibit~~market 4conditions warrant.1 The Repurchase Program will allow the Company to repurchase shares opportunistically at prices that the Company’ deems appropriate and subject to market conditions, applicable law and other factors deemed relevant in the Company's ~~Current~~sole ~~Report~~discretion. onSuch ~~Form~~repurchases 8may be effected through open market purchases, privately negotiated transactions or otherwise, including repurchase plans that satisfy the conditions of Rule 10b5-K1 ~~filed~~under onthe ~~July~~Securities 22Exchange Act of 1934, ~~2025~~as amended. The stock repurchase program does not obligate the Company to repurchase any dollar amount or number of shares of common stock, and ~~incorporated~~the byprogram ~~reference~~may ~~herein~~be suspended or discontinued at any time.

~~SIGNATURES~~A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference into this Item 8.01.

~~Pursuant~~Item to9.01 ~~the~~Financial ~~requirements~~Statements ofand ~~the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized~~Exhibits.

			Lite Strategy, Inc.
Exhibit Number		Exhibit Title
Date:	September 15, 2025	By:	/a/ Justin J. File
99.1		Press release, dated October 29, 2025
			Justin J. FileActing Chief Executive Officer, Chief Financial Officer and Secretary
104		Cover Page Interactive Data File (formatted as inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			LITE STRATEGY, INC.

Date:	October 30, 2025	By:	/s/ Justin J. File
			Justin J. File Acting Chief Executive Officer, Chief Financial Officer and Secretary

Filing Compare · Lite Strategy, Inc.